Consistently, the tumor weights and volumes in the ARHGAP25-OE group were significantly lower than those in the ARHGAP25-NC group, and vice versa in ARHGAP25 knockdown PAAD tumors (Figure 2E,F and S1,2). Here, ARHGAP25 is linked to pancreatic adenocarcinoma.